Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013, 157(4):277-279 | DOI: 10.5507/bp.2013.073

Multi-analytical evaluation of serum levels of cytokines and adhesion molecules in patients treated for acute myeloid leukemia using biochip array technology

Jan M. Horaceka,b, Martina Vasatovac, Tomas Kupsaa,b, Ladislav Jebavya,b, Pavel Zakb
a Department of Internal Medicine, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
b 4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove
c Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Hradec Kralove

Aims: Evaluation of serum levels of 17 cytokines and 5 adhesion molecules in patients treated for acute myeloid leukemia (AML) using biochip array technology. This approach allows multi-analytical determination from a single sample.

Methods: A total of 15 AML patients were studied. Blood samples were taken at the diagnosis (active leukemia) and at circa 6 months after completion of last chemotherapy (durable complete remission in all patients).

Results: Comparing cytokine and adhesion molecule levels in active leukemia and in durable complete remission, we found significant increase (P

Keywords: cytokines, adhesion molecules, biochip array, acute myeloid leukemia

Received: March 26, 2013; Accepted: September 17, 2013; Prepublished online: September 27, 2013; Published: December 12, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horacek, J.M., Vasatova, M., Kupsa, T., Jebavy, L., & Zak, P. (2013). Multi-analytical evaluation of serum levels of cytokines and adhesion molecules in patients treated for acute myeloid leukemia using biochip array technology. Biomedical papers157(4), 277-279. doi: 10.5507/bp.2013.073
Download citation

References

  1. Bruserud Ø, Kittang AO. The chemokine system in experimental and clinical hematology. Curr Top Microbiol Immunol 2010;341:3-12. Go to original source... Go to PubMed...
  2. Deeg HJ. Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction. Int J Hematol 2001;74(1):26-32. Go to original source... Go to PubMed...
  3. Lowenberg B, Touw IP. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993;81(2):281-92. Go to original source...
  4. Kupsa T, Horacek JM, Jebavy L. The role of cytokines in acute myeloid leukemia: a systematic review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012;156(4):291-301. Go to original source... Go to PubMed...
  5. Konopleva MY, Jordan CT. Leukemia stem cells and microenvironment: biology and therapeutic targeting. Clin Oncol 2011;29(5):591-9. Go to original source...
  6. Reikvam H, Hatfield KJ, Fredly H, Nepstad I, Mosevoll KA, Bruserud Ø. The angioregulatory cytokine network in human acute myeloid leukemia - from leukemogenesis via remission induction to stem cell transplantation. Eur Cytokine Netw 2012;23(4):140-53. Go to original source...
  7. Tsimberidou AM, Estey E, Wen S, Pierce S, Kantarjian H, Albitar M, Kurzrock R. The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes. Cancer 2008;113(7):1605-13. Go to original source... Go to PubMed...
  8. Kornblau SM, McCue D, Singh N, Chen W, Estrov Z, Coombes KR. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. Blood 2010;116(20):4251-61. Go to original source... Go to PubMed...
  9. Fung FY, Li M, Breunis H, Timilshina N, Minden MD, Alibhai SM. Correlation between cytokine levels and changes in fatigue and quality of life in patients with acute myeloid leukemia. Leuk Res 2013;37(3):274-9. Go to original source... Go to PubMed...
  10. Berrahmoune H, Lamont J, Fitzgerald P, Visvikis-Siest S. Inter-individual variation of inflammatory markers of cardiovascular risks and diseases. Clin Chem Lab Med 2005;43(7):671-84. Go to original source... Go to PubMed...
  11. Karasek D, Vaverkova H, Halenka M, Budikova M, Novotny D. Soluble cell adhesion molecules s-VCAM-1 and s-ICAM-1 in subjects with familial combined hyperlipidemia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005;149(1):101-8. Go to original source... Go to PubMed...
  12. Kavsak PA, Lee A, Hirte H, Young E, Gauldie J. Cytokine elevations in acute coronary syndrome and ovarian cancer: a mechanism for the up-regulation of the acute phase proteins in these different disease etiologies. Clin Biochem 2008;41(7-8):607-10. Go to original source... Go to PubMed...
  13. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420(6917):860-7. Go to original source... Go to PubMed...
  14. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004;4(1):11-22. Go to original source... Go to PubMed...
  15. Peric A, Vojvodic D, Baletic N, Peric A, Miljanovic O. Influence of allergy on the immunomodulatory and clinical effects of long-term low-dose macrolide treatment of nasal polyposis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010;154(4):327-33. Go to original source... Go to PubMed...
  16. McAleer D, McPhillips FM, FitzGerald SP, McConnell RI, Rodriguez ML. Application of Evidence Investigator for the simultaneous measurement of soluble adhesion molecules: L-, P-, E-selectins, VCAM-1 and ICAM-1 in a biochip platform. J Immunoassay Immunochem 2006;27(4):363-78. Go to original source... Go to PubMed...
  17. Fitzgerald SP, McConnell RI, Huxley A. Simultaneous analysis of circulating human cytokines using a high-sensitivity cytokine biochip array. J Proteome Res 2008;7(1):450-5. Go to original source... Go to PubMed...